Despite the continued success of Apple's health monitoring applications, in the diagnosis of cardiovascular diseases, from Carlertino they think there is still much to be done. So, this week the company announced a new one Alinaza and Johnson and Johnson development of clinical research that looks at these types of conditions.
Specifically, the new research, which will take three years, aims to gather more information about atrial fibrillation and other conditions followed by the iPhone and Apple Watch. Presented as "A Study of Hearts", the study will include a request for ourseiPhonehuria and examine whether follow-up health care follow-up and CardíaApple Watchaba cardiovascular activities can improve health outcomes, for people over 65.
Apple focuses on heart health
In the meantime, Apple and John Johnson & Johnson look to see if Apple's health tracking technology can help reduce the risk of stroke thanks to the early diagnosis of atrape fibrillation, which is one of the leading causes of stroke, but in many cases it is difficult to diagnose due to the lack of physical symptoms in many patients.
According to Myoung Cha, Apple Chief of Strategic Health Initiatives, Apple's technology contributes greatly to scientific research:
The Heartline study will help us better understand how our technology can impact science and help improve health outcomes, including reducing the risk of stroke.
The study will have them as case studies persons 65 years of age or older Citizens of the United States Must have traditional Medicare, have ourseiPhoneourse 6s or later (with iOS 12.2 or later) and agree to provide their Medicare application details. Once elected they will be divided into two groups; some to test apps on the iPhone and others to Apple Watch.
